43238
Shandong Weigao Group Medical Polymer Co., Ltd.
Dec 18, 2019
China
East Asia and the Pacific
Jun 12, 2021
B - Limited
Active
Approved : Mar 31, 2020
Signed : Mar 31, 2020
Invested : Jun 30, 2020
other
Health, Education and Life Sciences
Regional Industry - MAS Asia & Pac
Shandong Weigao Group Medical Polymer Company Limited, (“Weigao” or the “company” - http://en.weigaogroup.com/index.php/home/category/index/sc_id/index.php) listed on the Hong Kong Stock Exchange, is a leading manufacturer of single-use medical devices in China.
Weigao is organized into three operating divisions: (i) Single-use consumables (infusion set, syringes, medical needles, blood bags, pre-filling syringes, blood sampling products), (ii) orthopedic products, and (iii) interventional products. Weigao’s manufacturing operations are situated mainly in Weihai, Shandong Province, and in Qionglai, Sichuan Province. Weigao also has a number of other subsidiaries in the group, viz.: Weigao Medical Device; Weigao Orthopedic and Argon Medical (in United States).
IFC is considering an investment in Weigao through a long-term green bond of RMB 1 billion (approx. US$142 million equivalent) for implementation of resource efficiency and environmental protection measures, such as: power optimization with retrofit transformers, wastewater recycling plant and electron beam sterilization (thereby replacing ethylene oxide) across its manufacturing operations (the “project”). The use-of-proceeds of the proposed green bond will be certified against Global Green Bond Principles issued by International Capital Market Association (ICMA).
IFC supported previous projects with the company as follows:
“Weigao II” in 2014 (https://disclosures.ifc.org/#/projectDetail/ESRS/34313); and “Weigao” in 2006 (https://disclosures.ifc.org/#/projectDetail/ESRS/25099).
IFC’s review of the proposed investment consisted of appraising environmental, health and safety (EHS) and social information submitted by Weigao, including: Human Resource (HR) policies and procedures; safety management procedures (especially on employee safety, emergency response and pollution control); facilities management, life and fire safety (LFS), resource efficiency related documents; and corporate annual report.
The appraisal also included visits to Weigao headquarters and workshop facilities in Weihai, China in November 2019. Meetings were held with the corporate senior management from the company (Chairman and CFO, Chief Engineer and Head of Business Development). Similarly, discussions were held with the Director of HR, Manager of Safety and Technology Department, Manager of Production Department, Manager of Securities Department and Manager of Environment Protection and Energy Equipment Department; as well as with the operational staff at the facility level.